Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Testing effect

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    1,179 result(s) found for: Testing effect. Displaying page 1 of 59.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2019-003766-41 Sponsor Protocol Number: COVERAGE Start Date*: 2020-09-16
    Sponsor Name:Amsterdam UMC-AMC
    Full Title: The effect of Voxelotor on Cerebral Perfusion and Oxygenation (Coverage Study)
    Medical condition: Sickle Cell Disease
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-001285-11 Sponsor Protocol Number: P20.XXX Start Date*: 2021-01-12
    Sponsor Name:Leiden University Medical Center
    Full Title: A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy – A strategy trial
    Medical condition: Chemotherapy-induced polyneuropathy
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2005-002386-37 Sponsor Protocol Number: IVN3ICD Start Date*: 2007-08-24
    Sponsor Name:Department of Cardiology, Aalborg Hospital
    Full Title: Intravenous infusion of n-3 polyunsaturated fatty acids and ventricular tackycardi in patients with implantable cardioverter defibrillator (ICD)
    Medical condition: Patients with an implantable cardioverter defibrillator (ICD-unit) for treatment for cardiac ventricular arrhythmias and for prevention of sudden cardiac death
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-000319-27 Sponsor Protocol Number: ALT-711-0527 Start Date*: 2007-07-02
    Sponsor Name:Alteon, Inc.
    Full Title: A Double-blind, Placebo-Controlled, Randomized Trial Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients with Chronic Heart Failure
    Medical condition: Heart Failure
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008908 Chronic heart failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-002972-26 Sponsor Protocol Number: LDN_7323 Start Date*: 2015-12-14
    Sponsor Name:Smerteklinikken
    Full Title: Low dose naltrexone for treatment of pain in patients with fibromyalgia - effect via central mechanism? A randomized, double-blinded, placebo-controlled, cross-over study
    Medical condition: Pain in patients with fibromylagia
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004867 10049475 Chronic pain LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2019-001450-26 Sponsor Protocol Number: LAX-01 Start Date*: 2019-06-28
    Sponsor Name:Institute for Public Health and Caring Sciences, Uppsala University
    Full Title: Can the experience of a diminished effect of local anesthetics be verified by an objective test?
    Medical condition: Local anesthetics for minor or more major procedures such as suturing lacerations, removing skin lesions, operating ingrown toenails, drilling and removing teeth etc.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10024760 Local anesthetic LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-001219-31 Sponsor Protocol Number: CLAF237A2387 Start Date*: 2006-09-20
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A single-center, double-blind, randomized, placebo-controlled, cross-over study to assess the effect of vildagliptin on the incretin effect in patients with type 2 diabetes treated with metformin
    Medical condition: Type II Diabetes
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-023331-42 Sponsor Protocol Number: IMIOXC Start Date*: 2010-12-15
    Sponsor Name:Department of Neurology, Odense University Hospital
    Full Title: Oxcarbazepine for the treatment of chronic peripheral neuropathic pain: predictors of response - a randomised, double-blind, placebo-controlled clinical trial
    Medical condition: Chronic peripheral neuropathic pain caused by polyneuropathy, postherpetic neuralgia and traumatic/surgical nerve injury.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10054095 Neuropathic pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2021-003514-39 Sponsor Protocol Number: GNCbumet Start Date*: Information not available in EudraCT
    Sponsor Name:Gillberg Neuropsychiatry Centre
    Full Title: Testing E/I imbalance in autism with Bumetanide – a parallel group randomized waitlist-control trial in adolescents and adults
    Medical condition: Autism Spectrum Disorder
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-001918-98 Sponsor Protocol Number: 31052015 Start Date*: 2016-01-12
    Sponsor Name:Vestre Viken HF
    Full Title: RATe control in Atrial Fibrillation II
    Medical condition: Permanent atrial fibrillation
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-016874-34 Sponsor Protocol Number: PicoPEX-2009-16.10.2009 Start Date*: 2010-02-22
    Sponsor Name:Plymouth Hospitals NHS Trust
    Full Title: A Study into the Effect of Mechanical Bowel Preparation on Aerobic Exercise Capacity as Measured by Cardiopulmonary Exercise Testing.
    Medical condition: We are investigating the effect of mechanical bowel preparation, such as Picolax, on aerobic exercise capacity in healthy volunteers.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-002673-38 Sponsor Protocol Number: CRLX030A2211 Start Date*: 2015-11-24
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A multicenter, randomized, double-blind, crossover placebo-controlled Phase II study to assess the effect of serelaxin versus placebo on high sensitivity cardiac troponin I (hs-cTnI) release in pat...
    Medical condition: Chronic Heart Failure
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004849 10008908 Chronic heart failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-000539-27 Sponsor Protocol Number: CLAF237A2307 Start Date*: 2004-09-08
    Sponsor Name:Novartis Sverige AB
    Full Title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 52 Weeks Treatment with LAF237 50 mg qd to Placebo in Drug-Naïve Patients with Type 2 Diabetes and Mild Hyperg...
    Medical condition: Type 2 Diabetes
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) FI (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2020-003601-66 Sponsor Protocol Number: CSEG101ANL01T Start Date*: 2021-07-14
    Sponsor Name:Amsterdam UMC - AMC
    Full Title: The Effect of Crizanlizumab on Cerebral Perfusion and Oxygenation in Sickle Cell Patients
    Medical condition: Sickle Cell Disease
    Disease: Version SOC Term Classification Code Term Level
    21.0 10010331 - Congenital, familial and genetic disorders 10040644 Sickle cell disease PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-002443-15 Sponsor Protocol Number: ICAF-BETA Start Date*: 2017-09-20
    Sponsor Name:York Teaching Hospitals NHS Foundation Trust
    Full Title: Improving cardiac function in high-risk surgical patients: exercise testing, biomarkers and beta-blockade
    Medical condition: Impaired VE/CO2 on cardio pulmonary exercise testing
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004849 10007648 Cardiovascular disease, unspecified LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-005470-41 Sponsor Protocol Number: CTR0028 Start Date*: 2006-11-16
    Sponsor Name:Regent Medical
    Full Title: Hibiscrub EN12791 Testing using current application and 2 new application methods
    Medical condition: This trial will be carried out on healthy volunteers. Hibiscrub is a 4% chlorhexidine glucnate based pre-operative surgical hand disinfectant. Volunteers are going to use the product in three dif...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-001708-31 Sponsor Protocol Number: Protokol_PPB_ACL_21042017 Start Date*: 2017-06-20
    Sponsor Name:Aarhus University Hospital
    Full Title: The effect of the popliteal plexus block on postoperative pain after reconstruction of the anterior cruciate ligament
    Medical condition: Postoperative pain after reconstruction of the anterior cruciate ligament
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000021343 10078191 Anterior cruciate ligament reconstruction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2017-004852-52 Sponsor Protocol Number: OPHT-141117 Start Date*: 2018-04-17
    Sponsor Name:Medical University of Vienna, Department of Clinical Pharmacology
    Full Title: The effect of Tetrahydrocannabinol on ocular hemodynamics in healthy subjects
    Medical condition: The study will be carried out in healthy subjects.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2005-002794-79 Sponsor Protocol Number: ADEN001 Start Date*: 2006-02-21
    Sponsor Name:Swansea NHS Trust
    Full Title: Effect of Intravenous Adenosine on neuro-psychological dysfunction post coronary artery bypass surgery
    Medical condition: Neuro psychological dysfunction post cardiac by-pass surgery
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-000540-98 Sponsor Protocol Number: 2005/495-31 Start Date*: 2006-04-10
    Sponsor Name:Karolinska University Hospital
    Full Title: Substudie Bröstmärta provocerad med iv bolus adenosin injektion i huvudstudie: Jämförelse mellan aktiv och passiv fysisk träning för behandling av persisterande angina pectoris - en randomiserad st...
    Medical condition: Refractory angina pectoris. Testing of sensitivity of chest pain provoked by iv bolus of adenosin before and after a training period with EECP (Enhanced External Counterpulsation) or physical exerc...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 05:38:14 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA